Figure 1From: Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching studyFlow chart for patient entry. LABA: Long-acting beta-agonist. NETT: National emphysema treatment trial.Back to article page